Westside Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Westside Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$1.7K	–	1475
2026 Q1	$1.7K	Sell	9 -28	-76%	-$4.89K	﹤0.01%	1339
2025 Q4	$6.29K	Buy	37 +9	+32%	+$1.38K	﹤0.01%	1199
2025 Q3	$3.69K	Hold	28	–	–	﹤0.01%	1290
2025 Q2	$2.97K	Hold	28	–	–	﹤0.01%	1194
2025 Q1	$3.48K	Hold	28	–	–	﹤0.01%	836
2024 Q4	$3.45K	Hold	28	–	–	﹤0.01%	834
2024 Q3	$3.12K	Hold	28	–	–	﹤0.01%	848
2024 Q2	$2.99K	Hold	28	–	–	﹤0.01%	837
2024 Q1	$3.37K	Hold	28	–	–	﹤0.01%	775
2023 Q4	$3.44K	Hold	28	–	–	﹤0.01%	742
2023 Q3	$3.62K	Hold	28	–	–	﹤0.01%	725
2023 Q2	$3.47K	Hold	28	–	–	﹤0.01%	738
2023 Q1	$4.1K	Hold	28	–	–	﹤0.01%	719
2022 Q4	$4	Hold	28	–	–	﹤0.01%	719
2022 Q3	$3	Hold	28	–	–	﹤0.01%	740
2022 Q2	$4	Hold	28	–	–	﹤0.01%	709
2022 Q1	$4	Hold	28	–	–	﹤0.01%	700
2021 Q4	$3	Hold	28	–	–	﹤0.01%	717
2021 Q3	$3	Hold	28	–	–	﹤0.01%	702
2021 Q2	$4	Buy	+28	New	+$4.85K	﹤0.01%	665

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Westside Investment Management's JAZZ Position: Q2 2026 in Review

Westside Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 9 shares — an estimated $1.7K sold.

Westside Investment Management first reported a position in JAZZ in Q2 2021 and held it in 20 quarters. The position peaked at $6.29K in Q4 2025. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Westside Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Westside Investment Management sold 9 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.7K.
Westside Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 20 quarters.
Westside Investment Management's Jazz Pharmaceuticals position peaked at $6.29K in Q4 2025.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.